123 related articles for article (PubMed ID: 36972328)
1. Delivery of siRNA using hyaluronic acid-guided nanoparticles for downregulation of CXCR4.
Çağdaş Tunalı B; Çelik E; Budak Yıldıran FA; Türk M
Biopolymers; 2023 Apr; 114(4):e23535. PubMed ID: 36972328
[TBL] [Abstract][Full Text] [Related]
2. Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells.
Mitra M; Kandalam M; Rangasamy J; Shankar B; Maheswari UK; Swaminathan S; Krishnakumar S
Mol Vis; 2013; 19():1029-38. PubMed ID: 23687439
[TBL] [Abstract][Full Text] [Related]
3. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
[TBL] [Abstract][Full Text] [Related]
4. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy.
Xia Y; Guo M; Xu T; Li Y; Wang C; Lin Z; Zhao M; Zhu B
Int J Nanomedicine; 2018; 13():1539-1552. PubMed ID: 29588583
[TBL] [Abstract][Full Text] [Related]
5. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
[TBL] [Abstract][Full Text] [Related]
6. A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids.
Wen J; Qiu N; Zhu Z; Bai P; Hu M; Qi W; Liu Y; Wei A; Chen L
Drug Deliv; 2021 Dec; 28(1):1055-1066. PubMed ID: 34078185
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid-fabricated nanogold delivery of the inhibitor of apoptosis protein-2 siRNAs inhibits benzo[a]pyrene-induced oncogenic properties of lung cancer A549 cells.
Lin CM; Kao WC; Yeh CA; Chen HJ; Lin SZ; Hsieh HH; Sun WS; Chang CH; Hung HS
Nanotechnology; 2015 Mar; 26(10):105101. PubMed ID: 25693888
[TBL] [Abstract][Full Text] [Related]
8. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-siRNA conjugate/reducible polyethylenimine complexes for targeted siRNA delivery.
Jang YL; Ku SH; Jin S; Park JH; Kim WJ; Kwon IC; Kim SH; Jeong JH
J Nanosci Nanotechnol; 2014 Oct; 14(10):7388-94. PubMed ID: 25942799
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA.
Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S
Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation.
Zhao MD; Cheng JL; Yan JJ; Chen FY; Sheng JZ; Sun DL; Chen J; Miao J; Zhang RJ; Zheng CH; Huang HF
Int J Nanomedicine; 2016; 11():1323-36. PubMed ID: 27099493
[TBL] [Abstract][Full Text] [Related]
12. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
Park K; Lee MY; Kim KS; Hahn SK
Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
Wang S; Zhang J; Wang Y; Chen M
Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
[TBL] [Abstract][Full Text] [Related]
14. Polyethyleneimine-Coated Gold Nanoparticles: Straightforward Preparation of Efficient DNA Delivery Nanocarriers.
Ortega-Muñoz M; Giron-Gonzalez MD; Salto-Gonzalez R; Jodar-Reyes AB; De Jesus SE; Lopez-Jaramillo FJ; Hernandez-Mateo F; Santoyo-Gonzalez F
Chem Asian J; 2016 Dec; 11(23):3365-3375. PubMed ID: 27685032
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronan-Metal Gold Nanoparticle Hybrids for Targeted Tumor Cell Therapy.
Sanfilippo V; Caruso VCL; Cucci LM; Inturri R; Vaccaro S; Satriano C
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349323
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.
Ganesh S; Iyer AK; Morrissey DV; Amiji MM
Biomaterials; 2013 Apr; 34(13):3489-502. PubMed ID: 23410679
[TBL] [Abstract][Full Text] [Related]
17. MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.
Yang X; Iyer AK; Singh A; Choy E; Hornicek FJ; Amiji MM; Duan Z
Sci Rep; 2015 Feb; 5():8509. PubMed ID: 25687880
[TBL] [Abstract][Full Text] [Related]
18. Bioconjugated Gold Nanoparticles Enhance siRNA Delivery in Prostate Cancer Cells.
Rahme K; Guo J; Holmes JD
Methods Mol Biol; 2019; 1974():291-301. PubMed ID: 31099011
[TBL] [Abstract][Full Text] [Related]
19. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
20. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
Jiang G; Park K; Kim J; Kim KS; Hahn SK
Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]